List of Excipients in API asenapine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing asenapine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Noven Therapeutics LLC | SECUADO | asenapine | 68968-0172 | BUTYLATED HYDROXYTOLUENE | 2033-07-25 |
Noven Therapeutics LLC | SECUADO | asenapine | 68968-0172 | ISOPROPYL PALMITATE | 2033-07-25 |
Noven Therapeutics LLC | SECUADO | asenapine | 68968-0172 | MINERAL OIL | 2033-07-25 |
Noven Therapeutics LLC | SECUADO | asenapine | 68968-0172 | POLYISOBUTYLENE | 2033-07-25 |
Noven Therapeutics LLC | SECUADO | asenapine | 68968-0172 | SODIUM ACETATE ANHYDROUS | 2033-07-25 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing asenapine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 | ANHYDROUS CITRIC ACID |
Sigmapharm Laboratories LLC | asenapine | 42794-016 | BUTYLATED HYDROXYTOLUENE |
Sigmapharm Laboratories LLC | asenapine | 42794-016 | COPOVIDONE |
Sigmapharm Laboratories LLC | asenapine | 42794-016 | CROSPOVIDONE |
Sigmapharm Laboratories LLC | asenapine | 42794-016 | MAGNESIUM STEARATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for asenapine
Excipient focus: ANHYDROUS CITRIC ACID
asenapine drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
asenapine drug variants containing ASPARTAME
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-359 |
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-361 |
Centaur Pharmaceuticals Private Limited | asenapine maleate | 64330-625 |
MSN LABORATORIES PRIVATE LIMITED | asenapine maleate | 69539-059 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing ASPARTAME
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
asenapine drug variants containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing BUTYLATED HYDROXYANISOLE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
STAT RX USA LLC | asenapine maleate | 16590-936 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
asenapine drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
STAT RX USA LLC | asenapine maleate | 16590-936 |
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-359 |
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-361 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
asenapine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-359 |
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-361 |
Centaur Pharmaceuticals Private Limited | asenapine maleate | 64330-625 |
MSN LABORATORIES PRIVATE LIMITED | asenapine maleate | 69539-059 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
asenapine drug variants containing COPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing COPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
asenapine drug variants containing CROSPOVIDONE
asenapine drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
asenapine drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
STAT RX USA LLC | asenapine maleate | 16590-936 |
Greenstone LLC | asenapine maleate | 59762-1091 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
asenapine drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
MSN LABORATORIES PRIVATE LIMITED | asenapine maleate | 69539-059 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
asenapine drug variants containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
asenapine drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
asenapine drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
asenapine drug variants containing MAGNESIUM STEARATE
asenapine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
asenapine drug variants containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
asenapine drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing MANNITOL
Excipient focus: MINERAL OIL
asenapine drug variants containing MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYISOBUTYLENE
asenapine drug variants containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing POLYISOBUTYLENE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 35 CASTOR OIL
asenapine drug variants containing POLYOXYL 35 CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing POLYOXYL 35 CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
asenapine drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Breckenridge Pharmaceutical Inc | asenapine maleate | 51991-359 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
STAT RX USA LLC | asenapine maleate | 16590-936 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
asenapine drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
asenapine drug variants containing SILICON DIOXIDE
asenapine drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE ANHYDROUS
asenapine drug variants containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing SODIUM ACETATE ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
asenapine drug variants containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing SODIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
asenapine drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
Organon Pharmaceuticals USA | asenapine maleate | 0052-0118 |
Allergan Inc | asenapine maleate | 0456-2402 |
STAT RX USA LLC | asenapine maleate | 16590-936 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
asenapine drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | asenapine maleate | 0456-2402 |
Greenstone LLC | asenapine maleate | 59762-1091 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
asenapine drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | asenapine | 42794-016 |
>Company | >Ingredient | >NDC |
asenapine drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | asenapine | 46708-198 |
Alembic Pharmaceuticals Limited | asenapine | 46708-544 |
Alembic Pharmaceuticals Inc | asenapine | 62332-198 |
Alembic Pharmaceuticals Inc | asenapine | 62332-544 |
Noven Therapeutics LLC | asenapine | 68968-0172 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.